Bone Marrow & Hematopoietic Stem Cell Transplant
The Bone Marrow and Hematopoietic Stem Cell Transplant program at Westchester Medical Center was originally launched in October 1983 with its first related allogeneic transplant patient. Since its launch, the program has grown substantially adding autologous and unrelated allogeneic transplants, and collection services to our program offerings. We are accredited by the National Marrow Donor Program® (NMDP).
Our team has pioneered many of the advances applied today as standard of care for this population, including:
- Defining the engraftment efficacy of peripheral stem cells versus bone marrow
- Evaluating an array of conditioning regimens designed to enhance tumor responsiveness while reducing toxicity and numerous conditioning strategies
- Testing supportive care regimens to improve the patient's overall transplant experience. To date, more than 2000 transplants have been performed by the group
The Blood Cell Transplant service is staffed by attending physicians who have a significant experience in the field. They include Dr. Tauseef Ahmed, Chief, Dr. Karen Seiter, Dr. Delong Liu, and Dr. Mehmet Ozkaynak, Pediatrics. In addition, we have two Nurse Coordinators, Oncology Clinical Social Workers, and a specially trained nursing staff.
The program is active in both pediatric and adult transplants. It performs related and unrelated allogeneic transplants, and maintains a minitransplant program which treats patients who are otherwise not eligible for a standard allogeneic transplant.
Patients are cared for on an 12-bed HEPA filtered unit. We perform high-resolution DNA typing through Histogenetic Inc. High resolution DNA typing can be performed at the molecular level and leads to much more sophisticated tissue tying information which in turn improves our match for the patient.
Contact us at (914) 493-1448.